secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2025-01-14T23:59:59+00:00
Accession:  0001683168-25-000347
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio raises $3.19M in registered direct offering and warrant placement
----------------------------------------------------------------------

- Gross proceeds of $3.19M; net ~$2.85M after fees and expenses.
- Sold 1,063,670 shares at $3.00/share; issued warrants for up to 2,127,340 shares at $3.00, exercisable 24 months.
- H.C. Wainwright acted as placement agent; received 7.5% cash fee plus 79,775 warrants at $3.75.
- Net proceeds to be used for working capital and general corporate purposes.
- Offering closed on January 14, 2025; priced at-the-market under Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825000347/0001683168-25-000347-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825000347/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-000347

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer